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EFFICACY OF INTERNAL AND EXTERNAL QUALITY
CONTROL IN CHEMICAL PATHOLOGY
Pages with reference to book, From 255 To 259 
Rukhsana Lalani, Mirza Naqi Zafar, Mohammad Khurshid  ( Clinical Laboratories, Department of Pathology, The Aga
Khan University Hospital, Stadium Road, Karachi-5. ) 
Abstract 
Quality control in chemical pathology is based on internal and external quality assessment. The internal
quality control in clinical chemistry section of AKUH laboratory is based on the analysis of
commercially available Beckman norma! and abnormal range control sera. These have known
concentrations of blood chemistry constituents. After repeated estimations, mean values of all
constituents were established for both normal and abnormal sera. Patients samples were analysed only
when both controls were within ± 2SD from the mean or one control reads within ± 2SD and the other
read between ± 2—3SD (once only) for each constituent. Samples were not analysed if one control was
greater than ± 3SD from the mean or both controls were greater than ± 2SD or one control was between
± 2—3 SD on two successive runs. External quality control sera with unknown constituent
concentrations were analysed twice monthly and results sent to Weilcome England. Our results were
compared with the mean of estimations by 1000 laboratories for each constituent. The acceptable
standard deviation from this mean for each constituent was ± 2SD. External quality control evaluated
our accuracy in wide ranges of constituent concentrations encountered and helped us identify under or
over reporting of differenit parameters, both substrates and enzymes, at high or low levels or vice versa
which internal quality control could not address. Hence external quality control formed the basis of our
corrective actions in terms of equipment and reagents. We conclude that internal quality control is
limited in the sense that its efficacy has to be tested by external quality assessment (JPMA 38: 255,
1988).
INTRODUCTION 
Quality control in chemical pathology is concerned with every stage of a procedure right from the
collection of the specimen from the patient to the receipt of the report by the clinician. It includes
patient’s identification and registration, transportation and prqcessing of specimen, and method of
reporting result. Monitoring of all these is essential in order to recognize and minimize errors. This
requires quality assurance which ultimately deals with the reliability of the analytical results. Many
studies of precision and accuracy in clinical laboratories1-5 emphasize the importance of quality
assurance scheme. Quality assurance in chemical pathology basically consists of internal quality
control and external quality assessment. Two procedures are complementary; internal quality control
primarily monitors day to day reproducibility, that is precision, and detects frank errors (ACCURACY)
in any one day’s procedures, while external quality assessment primarily aims at detecting constant
differences (“BIAS”) between the laboratory results and those of others and also establishes under or
over reporting of parameters.
This paper reports the daily internal quality control of chemistry parameters performed on Beckman
Autoanalyzer, using commercially available quality controlled sera and their assessment by external
quality control scheme by Weilcome Foundation, England.
MATERIALS AND METHODS 
Internal Quality Control:
A strict system of quality control was observed at all levels such as for the collection of the specimen,
its processing, instrumentation, and its maintenance and reporting of the results as recommended by the
College of American Pathologists (C.A.P.) for Laboratory Accredition Certificate . Internal quality
control was initiated in our laboratories using commercially available Beckman Quality Control sera on
our autoanalyzer Astra Ideal. Initial calibration and routine maintenance were carried out periodically
as recommended by the manufacturers.
Determination of acceptable standard deviations limits:
This was performed by running a control atleast 30 times on different days and times and calculating
the mean and standard deviation (SD) by using standard procedure6,7. The acceptable limits were
calculated by adding and substracting the value of 2SD to the observed mean for each chemistry
parameter. All control results are then plotted on Levy—Jennings chart8.
Criteria for acceptability of Results:
The following are the rules observed at The Aga Khan University Hospital Laboratory for evaluating
the control results:
(a) Both control (Normal and Abnormal levels) are within ± 2SD from the mean;
OR
(b) One control reads within ±2SD; the other between 2-3SD (once only).
Control runs are rejected if:
(a) One control is greater than ±3SD from the mean or,
(b) Both controls are greater than ±2SD from the mean, or
(c) One control is between 2—3SD on two successive runs.
External Quality Control:
It is a retrospective analysis of internal quality control results by an external agency whereby samples
provided by the agency are analyzed and the results sent back by each participant, which are evaluated
by the agency and calculated, showing the participant’s performance in comparison with the other
laboratories in the worldwide scheme. We participate in Burroughs Welcome Quality Assessment
Scheme in which more than 1500 international laboratories take part and the assessment is made for 31
parameters. The results comprise deviation of our estimations from other laboratories for each
chemistry and the bias of our laboratory for over or under reporting a particular parameter. The cycle
comprises 12 external quality control samples, twice monthly for a period of six months.
RESULTS 
The level of our commercial internal controls are given in
Table I showing some representative routine chemistry parameters HCO3, K+, Cholesterol, T. Bilirubin
GGT, AST, AP and Amylase. Mean values of constituents derived in our laboratory and the acceptable
standard deviation are also given. If any of the results, after calibration, is more than 2SD, the
instrument is recalibrated before samples are run. External quality control results are given in Table II.
It gives the range of constituent concentration encountered in the six month cycle -and mean of
acceptable ISD for each parameter for twelve samples.

In Figures I to 5 (x—x) Plot gives deviation of our results for representative chemistries from the
population mean in external quality control and also the Bias plots (0’ Points) which thow under or
over reporting of their chemistries at different constituent levels (Top of each figure).
Figures 1, 2, 3, 4, show that all 12 results of Bilirubin, GGT, Ainylase and Alkaline Phosphatase were
well within 2SD of population mean. Figure I for Bilirubin, Figure 2 for GGT ws that there is no bias
for over reporting in these chemistries. Figure 3 for Amylase shows that there is a tendency for over
reporting above the concentration of 250 lU/L, though all our results were well within 2SD. Figure 4,
Alkaline Phosphatase shows that there is a tendency for low reporting in the activity range of 150-170
IU/L. Here also, results were well within 2SD. figure 5 shows the results of cholesterol though within
2SD from the population mean, however all results were on the low side, (no ‘0’ points on the +ve
side).
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